Ryabinin V E
South-Ural State Medical University, Chelyabinsk, Russia.
Biomed Khim. 2015 Sep-Oct;61(5):545-59. doi: 10.18097/PBMC20156105545.
The review considers features of efferent therapy employing extracorporeal systems, the devices known as "artificial liver" and "bioartificial liver" in the treatment of liver insufficiency. Analysis of literature data shows the need for further development of these biomedical studies and the search for optimal solutions in the selection of the source of hepatocytes, the development of bioreactors and biomaterials forming the basis of devices like "bioartificial liver". Taking into consideration certain advantages and disadvantages typical for various methods of extracorporeal support of the functional state of the liver one can evaluate prior experience in the treatment of liver diseases and approaches to the development of new, more effective medical technologies.
该综述探讨了采用体外系统的传出疗法的特点,即“人工肝”和“生物人工肝”装置在治疗肝功能不全方面的应用。文献数据分析表明,有必要进一步开展这些生物医学研究,并在肝细胞来源选择、生物反应器开发以及构成“生物人工肝”等装置基础的生物材料研发方面寻找最佳解决方案。考虑到体外支持肝脏功能状态的各种方法所具有的某些优缺点,人们可以评估肝病治疗的既往经验以及开发更新、更有效医疗技术的方法。